BRCA1 regulates microtubule dynamics and taxane-induced apoptotic cell signaling

被引:45
|
作者
Sung, M. [1 ]
Giannakakou, P. [1 ]
机构
[1] Cornell Univ, Weill Med Coll, Dept Med, Div Hematol & Med Oncol, New York, NY 10065 USA
基金
美国国家卫生研究院;
关键词
BRCA1; microtubule; dynamics; taxane; drug resistance; MESSENGER-RNA EXPRESSION; POSITIVE BREAST-CANCER; GAMMA-TUBULIN-BINDING; ADJUVANT CHEMOTHERAPY; NUCLEAR ACCUMULATION; TUMOR-SUPPRESSOR; SUPPORTIVE CARE; DOCETAXEL PLUS; PROTEIN; PACLITAXEL;
D O I
10.1038/onc.2013.85
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The taxanes are effective microtubule-stabilizing chemotherapy drugs used in the treatment of various solid tumors. However, the emergence of drug resistance hampers their clinical efficacy. The molecular basis of clinical taxane resistance remains poorly understood. Breast cancer 1, early onset gene, BRCA1, is a tumor-suppressor gene, whose expression has been correlated with taxane sensitivity in many solid tumors including non-small cell lung cancer. However, the molecular mechanism underlying the relationship between BRCA1 (B1) expression and taxane activity remains unclear. To this end, we created a stable B1 knockdown A549 cell line (B1-KD) to investigate B1's role in microtubule biology and response to taxane treatment. We show that B1-KD rendered A549 cells resistant to paclitaxel (PTX), phenocopying clinical studies showing that low B1 expression correlated with taxane resistance. As previously reported, we show that loss of B1 enhanced centrosomal g-tubulin localization and microtubule nucleation. Interestingly, we found that the B1-KD cells exhibited increased microtubule dynamics as compared with parental A549 cells, as assessed by live-cell confocal microscopy using enhanced green fluorescent protein-tagged a-tubulin or EB1 protein. In addition, we showed that loss of B1 impairs the ability of PTX to induce microtubule polymerization using immunofluorescence microscopy and a cell-based tubulin polymerization assay. Furthermore, B1-KD cells exhibited significantly lower intracellular binding of a fluorescently labeled PTX to microtubules. Recent studies have shown that PTX-stabilized microtubules serves as a scaffold for pro-caspase-8 binding and induction of apoptosis downstream of induced-proximity activation of caspase-8. Here we show that loss of B1 reduces the association of pro-caspase-8 with microtubules and subsequently leads to impaired PTX-induced activation of apoptosis. Taken together, our data show that B1 regulates indirectly endogenous microtubule dynamics and stability while its loss leads to microtubules that are more dynamic and less susceptible to PTX-induced stabilization conferring taxane resistance.
引用
收藏
页码:1418 / 1428
页数:11
相关论文
共 50 条
  • [21] BRCA1 regulates γ-tubulin binding to centrosomes
    Sankaran, Satish
    Crone, Donna E.
    Palazzo, Robert E.
    Parvin, Jeffrey D.
    CANCER BIOLOGY & THERAPY, 2007, 6 (12) : 1853 - 1857
  • [22] BRCA1 negatively regulates ITPK1
    Luo, Donghui
    Luo, Kun
    2012 2ND INTERNATIONAL CONFERENCE ON APPLIED ROBOTICS FOR THE POWER INDUSTRY (CARPI), 2012, : 878 - 880
  • [23] Wild-Type BRCA1, but not Mutated BRCA1, Regulates the Expression of the Nuclear Form of β-Catenin
    Li, Huchun
    Sekine, Masayuki
    Tung, Nadine
    Avraham, Hava Karsenty
    MOLECULAR CANCER RESEARCH, 2010, 8 (03) : 407 - 420
  • [24] Cdk1 and BRCA1 target γ-tubulin to microtubule domains
    Hubert, Thomas
    Vandekerckhove, Joel
    Gettemans, Jan
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 414 (01) : 240 - 245
  • [25] BRCA1 regulates EGFR expression through microRNAs
    Kumaraswamy, Easwari
    Stecklein, Shane R.
    Augustine, Laura A.
    Jensen, Roy A.
    CANCER RESEARCH, 2011, 71
  • [26] The role of BRCA1 in androgen receptor signaling in prostate cancer cell lines
    Clark, PE
    Irvine, RA
    Park, JJ
    Press, MF
    Coetzee, GA
    JOURNAL OF UROLOGY, 2002, 167 (04): : 52 - 53
  • [27] BRCA1 regulates RHAMM function in breast cancer
    Fleisch, M. C.
    Yang, Y.
    Mei, Q.
    Sadat, F.
    Brandi, L.
    Iwaniuk, K. M.
    Honisch, E.
    Maxwell, C. A.
    Niederacher, D.
    CANCER RESEARCH, 2012, 72
  • [28] The efficacy of taxane chemotherapy for metastatic breast cancer in BRCA1 and BRCA2 mutation carriers
    Kriege, Mieke
    Jager, Agnes
    Hooning, Maartje J.
    Huijskens, Elisabeth
    Blom, Jannet
    van Deurzen, Carolien H. M.
    Bontenbal, Marijke
    Collee, J. Margriet
    Menke-Pluijmers, Marian B. E.
    Martens, John W. M.
    Seynaeve, Caroline
    CANCER, 2012, 118 (04) : 899 - 907
  • [29] BRCA1 16 years later: DNA damage-induced BRCA1 shuttling
    Yang, Eddy S.
    Xia, Fen
    FEBS JOURNAL, 2010, 277 (15) : 3079 - 3085
  • [30] βhCG regulates immune cell population in BRCA1 mutated breast cancers.
    Varghese, Geetu Rose
    Jaikumar, Vishnu Sunil
    Rajan, Arathi
    Latha, Neetha Rajan
    Patra, Dipyaman
    Srinivas, Priya
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (03) : 60 - 60